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ABSTRACT: Accurate dietary assessment is a challenge in nutritional research, needing powerful and robust tools for reliable
measurement of food intake biomarkers. In this work, we have developed a novel quantitative dietary fingerprinting (QDF)
approach, which enables for the first time the simultaneous quantitation of about 350 urinary food-derived metabolites,
including (poly)phenolic aglycones, phase II metabolites, and microbial-transformed compounds, as well as other compounds
(e.g., glucosinolates, amino acid derivatives, methylxanthines, alkaloids, and markers of alcohol and tobacco consumption). This
method was fully validated for 220 metabolites, yielding good linearity, high sensitivity and precision, accurate recovery rates,
and negligible matrix effects. Furthermore, 127 additional phase II metabolites were also included in this method after
identification in urines collected from acute dietary interventions with various foods. Thus, this metabolomic approach
represents one-step further toward precision nutrition and the objective of improving the accurateness and comprehensiveness
in the assessment of dietary patterns and lifestyles.
KEYWORDS: quantitative dietary fingerprinting (QDF), targeted metabolomics, dietary assessment,
ultra-high-performance liquid chromatography−tandem mass spectrometry, urine
■ INTRODUCTION
Accurate assessment of food intake is a keystone in nutritional
research, with the aim of monitoring dietary patterns in free-
living populations, understanding the association between
nutrition and health status, and ensuring compliance in dietary
intervention studies. This goal has traditionally been
accomplished using self-reporting methods, namely, food
frequency questionnaires, dietary recalls, or diet diaries. A
major limitation of these tools is the high prevalence of
misreporting as a result of their subjective nature.1 On the
other hand, the measurement of metabolomic dietary
biomarkers has emerged in recent years as a more reliable
approach for characterizing the nutritional status.2 In this
context, the food metabolome can be defined as the entire set
of metabolites coming from the ingestion, absorption, and
biotransformation of food components, comprising a myriad of
different compounds, including polyphenols, carotenoids,
glucosinolates, amino acids and derived metabolites, fatty
acids, and many others.3 In particular, (poly)phenolic
compounds constitute a diverse group of secondary metabo-
lites widely distributed in the plant kingdom, and these have
been proposed as suitable biomarkers of fruit and vegetable
consumption.4 After ingestion, polyphenols undergo extensive
metabolization by phase I and II enzymes, yielding
glucuronidated, sulfated, and methylated metabolites.5 How-
ever, numerous polyphenols are scarcely absorbed in the small
intestine as a result of their low bioavailability; therefore, they
are metabolized in the colon by gut microbiota into phenolic
acids and other easily absorbable metabolites, which, in turn,
can also be conjugated to their glucuronide and sulfate forms.6
Thus, original food compounds are usually detected in the
organism at very low concentration levels compared to their
biotransformed metabolites. Given this complexity of the food
metabolome, analytical methods with wide coverage and high
sensitivity are needed to assess the metabolic fingerprint of
foods and dietary patterns by monitoring the large number of
potential dietary biomarkers in biological samples. To this end,
targeted metabolomics based on mass spectrometry is a very
attractive strategy because it enables sensitive and specific
quantification of metabolites.7 The majority of previously
published studies in this field are based on the use of an
enzymatic hydrolysis step with the aim of estimating the
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concentrations of glucuronide and sulfate derivatives as
aglycone equivalents because of the lack of commercial
standards for many of these phase II metabolites.8 However,
this approach has important drawbacks, such as the loss of
relevant information about the chemical nature of phenolic
conjugates, the introduction of impurities from commercially
available enzyme preparations, and the underestimation of
polyphenol concentrations as a result of incomplete hydrolysis
and low recovery of free forms.9−11 Another proposed strategy
is the analysis of phase II metabolites using calibration curves
of the corresponding aglycones, which provides inaccurate
results as a result of the assumption that chromatographic and
mass spectrometric responses of conjugated compounds are
equivalent to those shown by their aglycones.12,13 However,
only a few validated methods have been reported for direct
quantification of phase II metabolites, with most of them
focused on specific phenolic classes.14−17
The aim of this work was the development and validation of
a quantitative targeted urinary nutrimetabolomic platform to
assess dietary patterns and lifestyle, termed as quantitative
dietary fingerprinting (QDF). To this end, solid-phase
extraction (SPE) was combined with ultra-high-performance
liquid chromatography coupled to tandem mass spectrometry
(UHPLC−MS/MS), which enabled the simultaneous quanti-
tation of almost 350 dietary markers, including (poly)phenolic
aglycones, phase II metabolites, microbial-transformed com-
pounds, and other dietary components.
■ MATERIALS AND METHODS
Chemicals and Urine Samples. The provenance of chemicals
and standards is detailed in the Supporting Information. Blank human
urine samples were collected from healthy volunteers after 1 week of a
low-polyphenol diet.15 Various dietary interventions were also
conducted to obtain urine samples enriched in food metabolites
with the aim of (a) looking for potential biomarkers for which
standards are not available and (b) applying the validated method-
ology to demonstrate its utility. For this purpose, healthy volunteers
(n = 3) were asked to follow a low polyphenol diet 2 days before the
interventions and then to supplement their diet by consuming the
following foods: orange, grapefruit, apple, red wine, beer, green tea,
coffee, soy sprouts, walnuts, and whole grain bread (detailed
information in Table S1 of the Supporting Information). These
foods were consumed at dinner, and then participants collected first
morning void urine samples. Samples were aliquoted and stored at
−80 °C until analysis. The study was performed in accordance with
the principles contained in the Declaration of Helsinki. The Bioethical
Committee of the University of Barcelona approved the study
protocol, and all of the participants provided written informed
consent. The study was inscribed as ISRCTN17200423 in the
International Standard Randomized Controlled Trial Number
registry.
Sample Treatment. Urine samples were thawed in an ice bath
and then centrifuged at 10000g for 10 min at 4 °C. Then, different
sample treatment procedures were compared, including dilution and
two complementary SPE devices, Oasis HLB and Oasis MAX 96-well
plates, filled with 30 mg of sorbent (Waters, Milford, MA, U.S.A.). For
SPE extraction, a Waters Positive Pressure-96 Processor was
employed.
Urine Dilution. A 50 μL aliquot of the previously centrifuged urine
was diluted with 50 μL (1:1, v/v), 450 μL (1:10, v/v), or 950 μL
(1:100, v/v) of ultrapure water containing 0.1% formic acid (v/v).
Taxifolin was added as an internal standard (IS) to reach a final
concentration of 100 μg L−1, and samples were transferred to 96-well
plates for further analysis.
SPE (MAXMixed-Mode Sorbent). SPE using the Oasis MAX
plate was performed following the method described by Zamora-Ros
et al., with some modifications.18 Briefly, the sorbent first had to be
conditioned with methanol and 50 mM sodium acetate (pH 7). Then,
1 mL of urine containing H3PO4 (2%, v/v) and 100 μg L
−1 of a set of




onto the pre-conditioned plate. Plates were washed with 5% methanol
in 50 mM sodium acetate (pH 7), and analytes were eluted with 2%
formic acid in methanol (v/v). Finally, extracts were taken to dryness
using a MaxiVac β vacuum concentrator (Daejeon, South Korea) and
then reconstituted with 100 μL of taxifolin (100 μg L−1) dissolved in
the mobile phase as the IS.
SPE (HLBReversed-Phase Sorbent). Three extraction protocols
based on the use of Oasis HLB plates were compared. (i) First, we
applied the method developed by Urpi-Sarda et al., which employs
methanol and 1.5 M formic acid in water for SPE cartridge
conditioning.19 After acidulated urine (2%, v/v, H3PO4) was loaded,
spiked with the set of isotopically labeled ISs previously described,
cleanup was performed with 1.5 M formic acid and 5% methanol in
water. Finally, retained metabolites were eluted with methanol
containing 0.1% formic acid. (ii) To improve the extraction of sulfate
metabolites, a slight modification of a previously described method
was also tested on the basis of the application of a two-step elution
process with 0.5 mL of 0.1% ammonia in methanol and 1 mL of 0.1%
formic acid in methanol.20 (iii) In the same vein, we also evaluated the
utility of adding ammonium formate to SPE solvents to increase
extraction recoveries. For this, plates were conditioned with 1 mL of
methanol and 1 mL of water containing 0.1% formic acid and 10 mM
ammonium formate. Then, 1 mL of acidulated urine containing the
set of primary ISs was loaded, followed by 1 mL of water containing
0.1% formic acid and 10 mM ammonium formate. Finally, elution was
accomplished with 1.5 mL of methanol containing 0.1% formic acid
and 10 mM ammonium formate. All of these extracts were taken to
dryness using a vacuum concentrator and were then reconstituted
with 100 μL of taxifolin (100 μg L−1) dissolved in the mobile phase as
the IS.
UHPLC−MS/MS Analysis. Targeted metabolomic profiling of the
urinary food metabolome was carried out on an Agilent 1290 Infinity
UHPLC system (Santa Clara, CA, U.S.A.) coupled to a Sciex QTRAP
6500 mass spectrometer equipped with Ion Drive Turbo V ion source
(Framingham, MA, U.S.A.). The column used was a 100 × 2.1 mm
(1.6 μm inner diameter) Luna Omega Polar C18, equipped with a
fully porous polar C18 security guard cartridge from Phenomenex
(Torrance, CA, U.S.A.). Chromatographic conditions were as follows:
column temperature, 40 °C; autosampler temperature, 4 °C; injection
volume, 2 μL; and flow rate, 0.5 mL min−1. Two different mobile
phase combinations were employed depending upon the ionization
mode of data acquisition. In the negative ion mode, 0.1% formic acid
and 10 mM ammonium formate in water and pure acetonitrile were
delivered as aqueous (A) and organic (B) mobile phases, respectively.
The gradient program was as follows: 0−8 min, 5−20% B; 8−10 min,
20−100% B; 10−12 min, 100% B; 12−12.1 min, 100−5% B; and
12.1−14 min, 5% B. On the other hand, water and acetonitrile, both
containing 0.5% formic acid, were used as mobile phases when the
mass spectrometer operated in the positive ion mode. In that case, the
gradient profile was as follows: 0−5 min, 5−50% B; 5−5.1 min, 50−
100% B; 5.1−7 min, 100% B; 7−7.1 min, 100−5% B; and 7.1−9 min,
5% B.
MS detection was performed using the scheduled multiple reaction
monitoring (sMRM) mode. The mass spectrometer operated in
positive and negative ionization modes in separate runs, using the
following parameters: ion spray voltage, +5500/−4000 V; source
temperature, 600 °C; curtain gas, 30 psi; ion source gases 1 and 2, 50
psi each; collision-activated dissociation gas, 3 psi; and entrance
potential, (±)10 V. The multiple reaction monitoring (MRM)
transitions were optimized by infusing individual solutions of
commercial standards dissolved in the mobile phase (1:1, v/v,
proportion A/B, 500 μg L−1) into the mass spectrometer using a
syringe pump at a flow rate of 5 μL min−1. The method also included
some phase II metabolites identified in urine samples by product ion
scan monitoring, for which authentic standards were not available.
Journal of Agricultural and Food Chemistry Article
DOI: 10.1021/acs.jafc.8b07023
J. Agric. Food Chem. XXXX, XXX, XXX−XXX
B
Their MRM parameters were estimated on the basis of results
obtained with structurally similar standards (see the Application to
Real Urine Samples: Identification of Novel Conjugate Metabolites
section). Because of the large number of compounds monitored in
narrow retention time (RT) windows, the target scan time was set at
0.1 s. Optimized MRM transitions, declustering potentials (DPs),
collision energies (CEs), cell exit potentials (CXPs), RTs, and RT
windows are listed in Table S2 of the Supporting Information. Analyst
1.6.2 and MultiQuant 3.0.3 software (ABSciex, Framingham, MA,
U.S.A.) were used for data acquisition and data processing,
respectively.
Method Validation. The optimized SPE−UHPLC−MS/MS
method was validated according to the guidelines defined by the
U.S. Food and Drug Administration (FDA) for bioanalytical method
validation.21 Calibration curves were prepared in both solvent and
blank urine at 12 concentration levels in the range 0.01−2000 μg L−1
by diluting individual stock solutions of standards (1000 mg L−1).
Method specificity was evaluated by comparing the RT of authentic
standards dissolved in solvent and blank urine. The limits of
quantification (LOQs) were estimated in spiked urines as the lowest
concentration that gives an average signal-to-noise (S/N) ratio above
10, with accuracies varying from 80 to 120% of the theoretical value.
LOQs were calculated by subtracting the analyte response observed in
non-spiked blank urines. Intra- and interday precisions were evaluated
by analyzing spiked urine samples at three concentration levels (1, 10,
and 100 μg L−1) 5 times within the same day as well as on 3
consecutive days, respectively. Recoveries were determined in urine
samples spiked at three concentration levels (1, 10, and 100 μg L−1),
which were analyzed in triplicate. Matrix effects (MEs) were measured
by comparing the analyte response of standards dissolved in solvent
and urine at the same concentration level (100 μg L−1).
Table 1. Metabolites Included in the QDF Approach as Food Intake Biomarkers
metabolite class food reference
hydroxybenzoic acids: derivatives of benzoic, hippuric, gallic, (iso)vanillic, and
syringic acids
fruits and vegetables, tea, coffee, cocoa, grains, nuts,
legumes, olive oil, and wine
22−29
hydroxyphenylacetic acids: derivatives of phenylacetic and homovanillic acids fruits and vegetables, tea, cocoa, olives and olive oil,
and wine
22−24, 28, and 29
hydroxycinnamic acids: derivatives of coumaric, caffeic, (iso)ferulic, and sinapic acids fruits and vegetables, coffee, cocoa, grains, nuts,
legumes, olive oil, and wine
22−29
hydroxyphenylpropionic acids: derivatives of phenylpropionic, dihydrocaffeic, and
dihydro(iso)ferulic acids
fruits and vegetables, coffee, tea, cocoa, grains, and
olive oil
22−25 and 28
flavan-3-ols: (epi)catechin derivatives fruits (berries and apple), tea, cocoa, nuts, legumes,
and wine
23, 24, 26, 27, 29,
and 30
hydroxyphenylvalerolactones: derivatives of phenylvaleric acid and
phenylvalerolactones (microbial metabolites of flavan-3-ols)
procyanidin-rich foods (berries, apple, tea, cocoa, wine,
nuts, and legumes)
23, 24, 26, 27, 29,
and 30
flavanones: derivatives of naringenin and hesperetin citrus fruits and tomato (minor) 31
isoflavones: derivatives of daidzein, genistein, equol, biochanin A, and formononetin soy and legumes 27
flavones: derivatives of apigenin and luteolin fruits and vegetables, grains, olive oil, and legumes 31
flavonols: derivatives of quercetin, kaempferol, and isorhamnetin fruits and vegetables, tea, wine, nuts, olive oil, and
legumes
32
anthocyanins: derivatives of cyanidin, peonidin, malvidin, pelargonidin, peonidin, and
petunidin
wine and berries 29
dihydrochalcones: phloretin derivatives apple 30
stilbenes: resveratrol derivatives wine 29
phenylethanoids: tyrosol derivatives olive oil 28
lignans: derivatives of enterolactone and enterodiol (microbial metabolites) fiber-rich fruits and vegetables, grains, nuts, and
legumes
32
prenylflavonoids: isoxanthohumol beer 33
coumarins: derivatives of bergaptol and umbelliferone fruits (Rutaceae) and vegetables (Umbelliferae) 34
curcuminoids: curcumin derivatives Curcuma 31
urolithins: microbial metabolites of ellagitannins berries, wine, pomegranate, and nuts 16
other polyphenols: derivatives of pyrogallol, catechol, and hydroxybenzaldehydes
(microbial metabolites)
fruits and vegetables 35 and 36
benzoxazinoids: derivatives of aminophenol and hydroxyphenylacetamide (microbial
metabolites)
grains 37
glucosinolates: sulforaphane derivatives cruciferous vegetables (cabbage, broccoli, and Brussels
sprouts)
38
S-allylcysteine derivatives Allium vegetables (garlic and onion) 39
glycoalkaloids: α-solanine, α-chaconine, and solanidine potato 40
pyridinium derivatives: trigonelline and N-methylpyridinium coffee and legumes 41
amino acid derivatives and endogenous: 1/3-methylhistidine, carnosine, anserine,
L-carnitine, and creatinine
meat, fish, and dairy products 42 and 43
methylxanthines: derivatives of xanthine and uric acid coffee, tea, and cocoa 23 and 24
diketopiperazines: cyclo(Leu-Pro) and cyclo(Pro-Val) heat-treated foods (coffee and cocoa) 23 and 24
furan derivatives (Maillard reaction products) heat-treated foods (coffee, grains, and fruits and
vegetables)
44
polycyclic compounds: PhIP-G and 1-hydroxypyrene glucuronide heat-treated meat and fish 45
ethanol derivatives: ethyl glucuronide and sulfate alcoholic beverages 46
proline betaine and 4-hydroxyproline betaine citrus fruits 47
artificial sweeteners: acesulfame, cyclamate, and saccharin sweetened beverages 23
pyridine alkaloids: derivatives of nicotine and cotinine smoking status 48
others: TMAO, arsenobetaine, ergothioneine, tartaric acid, and hordenine fish and seafood, mushrooms, wine, and beer 33, 44, 49, and 50
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■ RESULTS AND DISCUSSION
The QDF approach validated in this work is based on
quantitative targeted nutrimetabolomic analysis of urine
samples for comprehensive dietary assessment. To this end,
we considered almost 350 dietary compounds and their host
and microbial metabolites based on the knowhow of the
research group and previous findings in metabolomic studies
associated with the consumption of certain foods or dietary
patterns (Table 1).22−48,49,50 These dietary compounds belong
to different chemical classes, which were selected taking into
consideration the potential biotransformations occurring after
food intake and the availability of commercial standards, to
obtain a representative overview of the food metabolome.
Most of these monitored dietary markers (∼90%) were
(poly)phenolic compounds, including phenolic acids, hydrox-
ybenzenes and hydroxybenzaldehydes, flavonoids, coumarins,
stilbenoids, tyrosol derivatives, and enterolignans, as well as
microbiota-derived urolithins and hydroxyphenylvalerolac-
tones. In turn, phenolic acids can be further divided into
several subclasses, such as hydroxybenzoic, hydroxyphenyl-
acetic, hydroxycinnamic, and hydroxyphenylpropionic acids,
while the flavonoid family comprises flavan-3-ols, flavanones,
flavones, flavonols, isoflavones, dihydrochalcones, and antho-
cyanins (Table 1). Moreover, other non-polyphenolic analytes
were also covered in this method, including glucosinolates,
amino acid derivatives (e.g., peptides and S-allylcysteine),
methylxanthines, alkaloids, and other miscellaneous com-
pounds. To obtain accurate metabolic patterns associated
with dietary habits, we carefully optimized and validated a
metabolomic platform based on SPE−UHPLC−MS/MS
operating in negative and positive ion modes, as schematized
in Figure 1.
Optimization of the Urine Treatment Method.
Dilution was first tested as the sample treatment method
prior to targeted UHPLC−MS/MS profiling given the
difficulty of optimizing an extraction protocol for the recovery
of the entire set of dietary metabolites included in this study.
The analysis of blank urine samples spiked with known
concentrations of standards demonstrated that 10-fold dilution
is the optimum dilution factor to minimize MEs provoked by
the high salt content of this biofluid. However, this strategy
yielded LOQs above 10 μg L−1 for almost all compounds
monitored, which would significantly hinder the detection of
these dietary markers in real urine samples. Accordingly,
various SPE procedures were compared to the aim of
increasing method sensitivity. First, preliminary experiments
were conducted to select the most appropriate SPE sorbent.
Reversed-phase resins are commonly employed for the cleanup
of complex biological samples and the extraction of numerous
dietary components, especially polyphenols.51 Nevertheless,
the application of anion-exchange SPE has also been proposed
to increase the recovery of acidic compounds, such as phase II
sulfate-derived metabolites. In this work, we compared the
performance of Oasis HLB and Oasis MAX plates for the
Figure 1. Flowchart showing the different steps considered for the optimization of the QDF approach.
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extraction of urinary dietary markers following previously
optimized protocols.18,19 The use of MAX sorbents provided
slightly higher recovery rates for a few flavan-3-ols (e.g.,
procyanidins B2, Dp3 and Dp4, and epigallocatechin) and
some sulfate metabolites (e.g., curcumin O-sulfate and
hesperetin 7-sulfate) (results not shown), but in general
terms, reversed-phase SPE was best suited to the simultaneous
extraction of different chemical classes of food compounds
(extraction recovery ratios of HLB/MAX in the range of 0.06−
350; 15 times higher on average for HLB). Once the HLB
plate had been selected, various solvents and SPE conditions
were tested to maximize extraction recoveries, especially for
sulfate metabolites poorly retained in this sorbent. For this
purpose, we first tried the two-step method proposed by
Khymenets et al. for sequential elution of glucuronide and
sulfate species of epicatechin metabolites present in human
breast milk using acidified and basic methanol, respectively.20
In the same vein, the utility of adding ammonium formate to
SPE solvents to improve the extraction of polar compounds in
reversed-phase resins was also checked. Similar results were
obtained using these two SPE procedures (no significant
differences tested by the t test; p > 0.05), with good recoveries
for aglycone, glucuronide, and sulfate forms of food
metabolites. Therefore, the SPE method based on the use of
ammonium formate as a modifier was selected for further
analyses as a result of its greater simplicity. Finally, we also
evaluated the potential of introducing a pre-concentration step
in this extraction protocol to increase method sensitivity. We
first tried to reduce the total volume of the elution solvent
below 1 mL (the volume of urine loaded into the SPE plate),
but recovery rates were negatively affected. As experimentally
checked, higher extraction efficiencies were achieved using 1.5
mL of methanol containing 0.1% formic acid and 10 mM
ammonium formate as the elution solvent. Alternatively, SPE
extracts were taken to dryness using a vacuum concentrator
and were then reconstituted in 100 μL of mobile phase,
thereby applying a 10-fold pre-concentration factor. Interest-
ingly, no substantial losses were observed during this
evaporation step for any analyzed metabolite (no significant
differences tested by the t test; p > 0.05), and furthermore,
UHPLC peak shapes were significantly improved.
The extraction performance of this SPE method was
excellent for most compounds detected by UHPLC−MS/MS
in the negative acquisition mode as well as for anthocyanins,
glucosinolates, methylxanthines, and some other metabolites
determined under positive ionization (see the Analytical
Validation of the QDF Method section). However, extraction
efficiency was very low for some flavan-3-ols, such as
procyanidins B2, Dp3 and Dp4, epigallocatechin, epicatechin
gallate, and epigallocatechin gallate, probably because of the
occurrence of strong interactions between these molecules and
the SPE sorbent, as previously described.52 It is also worth
noting that benzoic acid was not quantifiable using this
extraction procedure as a result of the presence of some
interfering compounds (checked in blank extracts). Con-
sequently, all of these metabolites were discarded for the
subsequent optimization of the UHPLC−MS/MS method. On
the other hand, a few highly polar metabolites (RT < 1 min)
showed low recovery rates as a result of their poor retention on
reversed-phase resins. As an alternative, urine samples were
complementarily analyzed after simple 10-fold dilution to
expand the coverage of our targeted metabolomic approach
toward the hydrophilic food metabolome, which comprises
conventional markers of the intake of meat and fish [1-
methylhistidine, 3-methylhistidine, carnosine, anserine, L-
carnitine, creatinine, and trimethylamine N-oxide (TMAO)],
Figure 2. Representative chromatograms of (A, D, and G) ferulic/isoferulic acid, (B, E, and H) ferulic/isoferulic sulfate, and (C, F, and I) ferulic/
isoferulic glucuronide, using (A, B, and C) 0.1% formic acid, (D, E, and F) 10 mM ammonium acetate at pH 5, and (G, H, and I) 10 mM
ammonium formate and 0.1% formic acid as the aqueous mobile phase.
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coffee (trigonelline and N-methylpyridinium), citrus fruits
(proline betaine and 4-hydroxyproline betaine), alcoholic
(ethyl glucuronide and ethyl sulfate) and sweetened
(acesulfame K and cyclamate) beverages, or tobacco (nicotine
and cotinine), among others.
Optimization of the Chromatographic Method.
Separation conditions were optimized to achieve good
resolution of metabolites listed in Table S2 of the Supporting
Information. To this end, we employed a reversed-phase
UHPLC column (Luna Omega Polar), which shows improved
retention of polar metabolites. Given the different physico-
chemical properties of metabolites monitored in this study, two
complementary UHPLC methods were developed for data
acquisition in negative and positive ionization modes.
As a preliminary experiment, we employed similar mobile
phases to those reported in previously published targeted
approaches for urinary polyphenol profiling based on HPLC−
MS operating in the negative ion mode, consisting of water and
acetonitrile both containing 0.1% formic acid.19 It is worth
noting that the use of UHPLC considerably increased
sensitivity and chromatographic separation compared to
those obtained in HPLC columns, but poor resolution was
observed for sulfate derivatives (Figure 2). To enhance the
peak shape of these phase II metabolites, we tested the mobile
phase proposed by Rotches-Ribalta et al. for the analysis of
urinary resveratrol metabolites based on the addition of
ammonium acetate to the aqueous phase to reduce the peak
tailing of sulfate conjugates.15 Thus, we observed a better peak
resolution using 10 mM ammonium acetate (pH 5) and
acetonitrile as aqueous and organic mobile phases, but in
contrast, signal intensities were considerably reduced for most
aglycone and glucuronide species (Figure 1). Because this loss
of sensitivity was probably a consequence of ion suppression
induced by this additive, we substituted ammonium acetate
with ammonium formate, which is more volatile. As a result,
even higher sensitivity to that observed without the addition of
any modifier was obtained and a good peak resolution was
maintained for sulfate metabolites (Figure 2). Then, different
ammonium formate concentrations (5−20 mM) and acidities
(pH 3−5, 0.1% formic acid) were tested, and the best results
were achieved using 10 mM ammonium formate and 0.1%
formic acid (pH 3.3). To conclude, we also evaluated the
separation performance of methanol as an organic mobile
phase, but a considerable worsening of peak shapes was
observed.
To optimize chromatographic conditions to be used in the
positive MS ion mode, we first tried the mobile phases
described above but broad chromatographic peaks were
observed for anthocyanins. Then, different concentrations of
formic acid, in the range of 0.1−1%, were tested to increase the
acidity of mobile phases, which is known to provide a better
resolution for anthocyanins.53 Accordingly, the addition of
0.5% formic acid to both aqueous and organic mobile phases
was proven to be the most suitable strategy for simultaneously
analyzing anthocyanins, glucosinolates, methylxanthines, and
other metabolites under positive electrospray ionization, as
listed in Table S2 of the Supporting Information.
After the selection of the mobile phase composition,
different chromatographic conditions were tested to achieve
the maximum separation of urinary metabolites, especially for
isomeric compounds. Various flow rates (0.4−0.8 mL min−1),
column temperatures (30−40 °C), and injection volumes (2−
5 μL) were studied, and optimum results were obtained by
delivering mobile phases at 0.5 mL min−1 and using 40 °C and
2 μL as the column temperature and injection volume,
respectively. In the negative ion mode, the optimized elution
program begins with a slow gradient within 8 min, ranging
from 5 to 20% of the organic mobile phase, with the aim of
obtaining a good separation of multiple phenolic acid isomers,
such as hydroxybenzoic acids, dihydroxybenzoic acids,
hydroxyphenylacetic acids, coumaric acids, and many others.
Then, the proportion of organic solvent rapidly rises to 100%
to elute more retained flavonoid metabolites. Under these
chromatographic conditions, all metabolites were resolved
within 10 min, with a 14 min total run time, including washing
and conditioning steps. On the other hand, dietary compounds
analyzed in positive polarity were separated using a single-
gradient program (5−50% B).
Optimization of the MS/MS Method. To maximize
ionization efficiency and overall sensitivity, general MS
parameters, such as source temperature, gas flow rates, and
ionization voltage, were first optimized by evaluating peak
areas and S/N ratios in extracted ion chromatograms. Then,
optimum MRM transitions and fragmentation conditions (i.e.,
DP, CE, and CXP) were selected by infusing standard
solutions into the mass spectrometer using a syringe pump
(Table S2 of the Supporting Information). For this, 500 μg L−1
individual solutions were prepared in a 1:1 (v/v) mixture of
acetonitrile and water containing 10 mM ammonium formate
and 0.1% formic acid for metabolites analyzed in the negative
ion mode or in a 1:1 (v/v) acetonitrile/water mixture
containing 0.5% formic acid for those ionized under positive
polarity. Two MRM transitions were optimized for each
analyte, with the most sensitive one for quantitation purposes
and the other as a qualifier transition. However, as a result of
the very large number of metabolites included in this study,
two separate acquisition methods were created (i.e.,
quantitative and qualitative methods) to maximize the number
of points across chromatographic peaks to obtain better peak
detection and improve reproducibility. For the same reason,
isomeric metabolites with common fragmentation patterns
were grouped within a single transition. Additionally, the
sMRM mode was employed instead of conventional MRM,
which allows for the simultaneous monitoring of multiple
transitions using RT windows. To establish these windows,
individual standard solutions were injected into the UHPLC−
MS system to find their RTs, and RT windows were then
estimated on the basis of peak widths and retention
reproducibility (Table S2 of the Supporting Information).
Analytical Validation of the QDF Method. The QDF
approach previously optimized on the basis of targeted
metabolomic analysis of urine samples by SPE−UHPLC−
MS/MS was validated according to the FDA guidelines in
terms of specificity, linearity, sensitivity, intra- and interday
precision, recovery rate, and MEs (Table S3 of the Supporting
Information). To evaluate method specificity, we compared
the retention time of standard compounds in spiked urine
samples to that observed when dissolved in the mobile phase.
RT deviations (ΔRT = RTsample − RTstd) were below 0.04 min
for all metabolites, thereby demonstrating the great stability of
the UHPLC system. For most monitored compounds,
calibration curves showed linear responses over 4−5 orders
of magnitude in the studied concentration range (0.01−1000
μg L−1), with correlation coefficients above 0.999. However,
these linear ranges were slightly reduced for some phenolic
acids as a result of their higher LOQs as well as for some very
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polar metabolites detected in the positive ion mode (RT < 1
min) probably as a result of ion suppression effects (see Table
S3 of the Supporting Information). The sensitivity of the
method was estimated by computing the corresponding LOQs
in spiked urine samples, which were calculated as the
concentration needed to produce a chromatographic signal
10 times higher than the baseline noise. From the entire set of
metabolites included in the method, 83% could be quantified
at sub-parts per billion (ppb) levels, while 28 of the remaining
metabolites displayed LOQs in the range 1−10 μg L−1. Only
nine phenolic acids showed quantification limits above 10 μg
L−1 (11.5−40.0 μg L−1). The results obtained were satisfactory
Figure 3. Extracted ion chromatograms acquired under negative ionization of representative metabolites present in urine samples. Metabolites
labeled in red were identified in urine samples collected after acute dietary interventions by MS3.
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for quantitating target compounds at concentrations usually
found in urine samples. Instrumental precision was evaluated
by analyzing blank urine samples spiked at three concentration
levels, 5 times within the same day (intraday precision) as well
as on 3 consecutive days (interday precision). Relative
standard deviations (RSDs) varied in the ranges of 0.7−12.8
and 1.7−17.1% for the intra- and interday precision,
respectively, suggesting that instrumental response is reprodu-
cible over a minimum period of 3 days. Recovery rates also met
the FDA acceptance criteria, ranging from 80 to 120% for
about 94% of the metabolites analyzed. Only a few flavonoid
aglycones showed slightly lower extraction efficiencies (70.2−
78.9%), while the SPE recovery of quercetin 3′-sulfate was




and L-phenylalanine-15N), recoveries were in the range of 87−
104%, thereby demonstrating the utility of this primary IS set
for monitoring the efficiency of the extraction process. Finally,
the ME was estimated to evaluate the performance of the
sample treatment method and the UHPLC separation program
for minimizing the impact of the urine matrix in the detection
of dietary compounds. For this purpose, MS responses were
compared for each standard dissolved in solvent and urine at
the same concentration level. Overall, MEs were negligible for
almost all compounds monitored (ME of 82.2−126%), except
for a few metabolites slightly affected by ion suppression (ME
of 61.1−79.5%), especially those analyzed in positive ion mode
after simple dilution (e.g., carnosine and 3-methylhistidine).
Therefore, given the good recovery rates and low MEs
obtained, the method could be applied to real urine samples
using calibration curves directly prepared in solvent, thereby
simplifying the analytical workflow.
In comparison to previous validated methods based on
targeted metabolomics, the QDF approach provides com-
parable linearity and intra- and interday precision.14−16
However, sensitivity and ME were significantly improved
thanks to the application of a reliable SPE protocol and further
pre-concentration step to simultaneously extract the urinary
food metabolome. This is especially remarkable when
comparing to high-throughput methods based on direct
analysis of diluted urine samples.
Application to Real Urine Samples: Identification of
Novel Conjugate Metabolites. After the optimization of the
SPE method, chromatographic conditions, and MS detection
parameters, the developed QDF metabolomic platform was
applied to urine samples collected after acute dietary
interventions with various foods with the aim of increasing
the number of biologically interesting phase II metabolites for
which commercial standards are not available to enlarge the
coverage of our dietary fingerprinting method. For this
purpose, product ion scan experiments (MS2) were conducted
using predicted nominal masses of these expected metabolites
and those peaks showing neutral losses of 176 Da (i.e.,
glucuronide conjugates) or 80 Da (i.e., sulfate conjugates)
were subjected to MS3 fragmentation of the corresponding
aglycone. Using this method, we successfully identified 127
urinary compounds associated with the consumption of
orange, apple, grapefruit, red wine, green tea, coffee, soy,
walnuts, and whole grain bread (Table S4 of the Supporting
Information). To include these potential dietary markers in our
targeted metabolomic approach, MRM transitions and
fragmentation parameters were estimated on the basis of
results obtained with available standards of other metabolites.
As a rule, we observed that DPs and CXPs optimized for phase
II conjugates with available authentic standards were very
similar to those employed for their aglycone counterparts. In
contrast, glucuronide and sulfate metabolites needed slightly
higher CEs to yield significant fragmentation than the
corresponding aglycone forms. Thus, MRM detection of
conjugates identified in urine samples was accomplished by
applying the following parameters: (i) quantifier MRM
transition, DPconjugate = DPaglycone, CXPconjugate = CXP1‑aglycone,
and CEconjugate = CE1‑aglycone + 5 V; (ii) qualifier MRM
transition, DPconjugate = DPaglycone, CXPconjugate = CXP1‑aglycone,
and CEconjugate = CE1‑aglycone + 15 V (Table S2 of the
Supporting Information). Thus, this optimized analytical
strategy enables the detection of these novel phase II
metabolites in a “semi-quantitative” manner, by either
quantifying them using calibration curves built with standards
of structurally similar compounds (i.e., the corresponding
aglycones or isomeric phase II metabolites, if available) or
measuring their peak area (relative to the IS).
Using this QDF methodology, about 350 compounds
representative of specific food class consumption could be
successfully measured in urine samples, thereby enabling a
comprehensive assessment of dietary habits. The analysis of
urine samples collected after dietary interventions with various
plant-derived foods showed a significant increase in the urinary
levels of phenolic acids. The most abundant free phenolic
compounds were 4-hydroxybenzoic acid, hippuric acids,
hydroxyphenylacetic acids, and homovanillic acid, while
among phase II metabolites, sulfate conjugates were very
concentrated in urine, largely surpassing the concentration
levels of the corresponding aglycone forms. Furthermore, the
consumption of specific foods was reflected in the excretion of
the following polyphenol metabolites: flavanone metabolites
(i.e., naringenin and hesperetin) were associated with orange
intake; isoflavones (i.e., daidzein and genistein) were
associated with soy; dihydrochalcones (i.e., phloretin) were
associated with apple; furanocoumarins (i.e., bergaptol) were
associated with grapefruit; prenylflavonoids (i.e., isoxanthohu-
mol) were associated with beer; flavan-3-ols were associated
with epicatechin-rich foods (e.g., apple and tea); flavones (i.e.,
apigenin and luteolin) and flavonols (i.e., quercetin, kaempfer-
ol, and isorhamnetin) were associated with fruits and
vegetables; enterolignans (i.e., enterolactone and enterodiol)
were associated with fiber-rich foods; stilbenoids (i.e.,
resveratrol) were associated with red wine; and tyrosol
metabolites were associated with olive oil, as summarized in
Figures 3 and 4. These food compounds underwent extensive
metabolization by phase II enzymes, thereby yielding a myriad
of glucuronide, sulfate, and sulfoglucuronide conjugates in
urine. However, the aglycone forms of some of these
flavonoids could also be detected at quantifiable concen-
trations in the urine samples analyzed in this study, such as
naringenin, bergaptol, phloretin, isoxanthohumol, daidzein,
and genistein, among others. The optimized method also
enabled the detection of various metabolites derived from
microbiota biotransformation of some scarcely absorbed food
components, including hydroxyphenylvalerolactones produced
in the ring-fission metabolism of catechins (apple and tea),
urolithins coming from ellagitannins (walnut), and amino-
phenol-derived metabolites [i.e., 2-aminophenol and N-(2-
hydroxyphenyl)acetamide] generated by microbial degradation
of bezoxazinoids (whole grain). These compounds were
mainly detected in urine samples as phase II metabolites
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(sulfated conjugates for valerolactones and benzoxazinoids and
glucuronidated conjugates for urolithins), but the correspond-
ing aglycones were also found. Additionally, the complemen-
tary analysis of urines in the positive ion mode expanded the
method coverage toward the determination of anthocyanins,
methylxanthines, glucosinolates, glycoalkaloids, and S-allylcys-
teine derivates, suitable dietary markers of the consumption of
berries; coffee, cocoa, and tea; cruciferous vegetables (e.g.,
cabbage and broccoli); potato; and vegetables from the Allium
genus (e.g., onion and garlic), respectively.
In conclusion, it should be noted that the QDF method-
ology optimized here shows a great potential for compre-
hensive assessment of dietary patterns and lifestyles, by
simultaneously analyzing about 350 urinary metabolic
biomarkers associated with the consumption of plant-derived
foods, animal foods, and alcoholic and non-alcoholic
beverages, as well as smoking status. This is a first step toward
the development of precision nutrition and medicine, because
it allows for quantification of the human diet in a robust and
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R.; Lamuela-Raventoś, R. M. Urinary tartaric acid as a potential
biomarker for the dietary assessment of moderate wine consumption:
A randomised controlled trial. Br. J. Nutr. 2014, 111, 1680−1685.
(51) Ajila, C. M.; Brar, S. K.; Verma, M.; Tyagi, R. D.; Godbout, S.;
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